{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:41:10Z","timestamp":1783478470182,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obesity is associated with the development of polycystic ovary syndrome (PCOS) and contributes substantially to metabolic abnormalities in women with PCOS. The study aimed to describe and compare the practices of physicians in the diagnosis, evaluation, and treatment of obesity in patients with PCOS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Reproductive endocrinologists (Repro-Endo) and obstetrician-gynecologists (non-reproductive medicine specialty, OB-Gyn) in China participated in a survey, and their responses were analyzed using \u03c7<jats:sup>2<\/jats:sup> tests, Fisher exact tests, and multivariable logistic regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study analyzed 1318 survey responses (85.8% OB-Gyn; 97.3% women). Body mass index was the most common diagnostic criterion for obesity; only 1.3% of participants measured waist circumference to identify abdominal obesity. More Repro-Endo participants (25% of all participants) enquired about the psychological problems of patients with obesity than OB-Gyn participants, and 42.5% of participants reported ordering both a lipid profile and oral glucose tolerance test (OGTT) for patients with obesity and PCOS. Multivariable analysis, that included physician\u2019s specialty, age, hospital grade, and number of patients with PCOS seen annually, revealed that OB-Gyn participants were less likely to order OGTT (OR, 0.3; 95% CI, 0.2\u20130.4) and lipid profile (OR, 0.2; 95% CI, 0.1\u20130.3) than Repro-Endo participants. The most common treatments for patients with PCOS were lifestyle modification (&gt;\u200995%) and metformin (&gt;\u200980%). More Repro-Endo participants prescribed metformin at a dose of 1.5\u2009g\/day compared with OB-Gyn (47.6% vs. 26.3%), and more OB-Gyn participants reported being unclear about the appropriate dosage of metformin for patients with obesity and PCOS (8.9% vs. 1.6%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our survey identified knowledge gaps in metabolic screening for patients with obesity and PCOS and a disparity in the evaluation and treatment of obesity in PCOS among different specialties. Similarly, it highlights the need to improve obesity management education for physicians caring for women with PCOS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12902-021-00848-w","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T13:02:59Z","timestamp":1630933379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Obesity management in polycystic ovary syndrome: disparity in knowledge between obstetrician-gynecologists and reproductive endocrinologists in China"],"prefix":"10.1186","volume":"21","author":[{"given":"Ruilin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-0906","authenticated-orcid":false,"given":"Aijun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"issue":"2","key":"848_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.orcp.2020.02.005","volume":"14","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang Z, Wang X, Chen Z, Shao L, Tian Y, et al. Prevalence of overweight and obesity in China: results from a cross-sectional study of 441 thousand adults, 2012-2015. Obes Res Clin Pract. 2020;14(2):119\u201326. https:\/\/doi.org\/10.1016\/j.orcp.2020.02.005.","journal-title":"Obes Res Clin Pract"},{"issue":"9882","key":"848_CR2","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/S0140-6736(13)61097-1","volume":"381","author":"G Yang","year":"2013","unstructured":"Yang G, Wang Y, Zeng Y, Gao GF, Liang X, Zhou M, et al. Rapid health transition in China, 1990-2010: findings from the global burden of disease study 2010. Lancet. 2013;381(9882):1987\u20132015. https:\/\/doi.org\/10.1016\/S0140-6736(13)61097-1.","journal-title":"Lancet."},{"issue":"5","key":"848_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrendo.2018.24","volume":"14","author":"HF Escobar-Morreale","year":"2018","unstructured":"Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270\u201384. https:\/\/doi.org\/10.1038\/nrendo.2018.24.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"848_CR4","first-page":"5","volume":"86","author":"L Iughetti","year":"2015","unstructured":"Iughetti L, Lucaccioni L, Predieri B. Childhood obesity and environmental pollutants: a dual relationship. Acta Biomed. 2015;86(1):5\u201316.","journal-title":"Acta Biomed"},{"issue":"3","key":"848_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00404-012-2568-z","volume":"287","author":"HY Zhang","year":"2013","unstructured":"Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study. Arch Gynecol Obstet. 2013;287(3):525\u201331. https:\/\/doi.org\/10.1007\/s00404-012-2568-z.","journal-title":"Arch Gynecol Obstet"},{"key":"848_CR6","doi-asserted-by":"publisher","first-page":"117955811987404","DOI":"10.1177\/1179558119874042","volume":"13","author":"TM Barber","year":"2019","unstructured":"Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042.","journal-title":"Clin Med Insights Reprod Health"},{"issue":"5","key":"848_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3109\/09513590.2015.1117069","volume":"32","author":"S Behboudi-Gandevani","year":"2016","unstructured":"Behboudi-Gandevani S, Ramezani Tehrani F, Rostami Dovom M, Farahmand M, Bahri Khomami M, Noroozzadeh M, et al. Insulin resistance in obesity and polycystic ovary syndrome: systematic review and meta-analysis of observational studies. Gynecol Endocrinol. 2016;32(5):343\u201353. https:\/\/doi.org\/10.3109\/09513590.2015.1117069.","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"848_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dex044","volume":"32","author":"LG Cooney","year":"2017","unstructured":"Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017;32(5):1075\u201391. https:\/\/doi.org\/10.1093\/humrep\/dex044.","journal-title":"Hum Reprod"},{"key":"848_CR9","first-page":"2","volume":"53","author":"S Endocrinology","year":"2018","unstructured":"Endocrinology S. Expert panel CSoO, Gyneocology CMA. Chinese guideline for diagnosis and management of polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi. 2018;53:2\u20136.","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"848_CR10","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1097\/AOG.0000000000002656","volume":"131","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology","year":"2018","unstructured":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Gynecology. ACOG Practice Bulletin No. 194: polycystic ovary syndrome. Obstet Gynecol. 2018;131:e157\u2013e71.","journal-title":"Obstet Gynecol"},{"issue":"9","key":"848_CR11","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","volume":"33","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):1602\u201318. https:\/\/doi.org\/10.1093\/humrep\/dey256.","journal-title":"Hum Reprod"},{"issue":"01","key":"848_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1055\/s-0038-1667155","volume":"36","author":"M Gibson-Helm","year":"2018","unstructured":"Gibson-Helm M, Dokras A, Karro H, Piltonen T, Teede HJ. Knowledge and practices regarding polycystic ovary syndrome among physicians in Europe, North America, and internationally: an online questionnaire-based study. Semin Reprod Med. 2018;36(01):19\u201327. https:\/\/doi.org\/10.1055\/s-0038-1667155.","journal-title":"Semin Reprod Med"},{"issue":"4","key":"848_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1530\/EJE-14-0252","volume":"171","author":"G Conway","year":"2014","unstructured":"Conway G, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Franks S, Gambineri A, et al. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS special interest Group's questionnaire. Eur J Endocrinol. 2014;171(4):489\u201398. https:\/\/doi.org\/10.1530\/EJE-14-0252.","journal-title":"Eur J Endocrinol"},{"key":"848_CR14","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.fertnstert.2017.04.011","volume":"107","author":"A Dokras","year":"2017","unstructured":"Dokras A, Saini S, Gibson-Helm M, Schulkin J, Cooney L, Teede H. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril. 2017;107:1380\u20136.e1.","journal-title":"Fertil Steril"},{"key":"848_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2265.2004.02208.x","volume":"62","author":"AJ Cussons","year":"2005","unstructured":"Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf). 2005;62:289\u201395.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"848_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.tem.2007.07.003","volume":"18","author":"HF Escobar-Morreale","year":"2007","unstructured":"Escobar-Morreale HF, San Mill\u00e1n JL. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab. 2007;18(7):266\u201372. https:\/\/doi.org\/10.1016\/j.tem.2007.07.003.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"848_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.numecd.2006.07.005","volume":"17","author":"SA Ritchie","year":"2007","unstructured":"Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis. 2007;17(4):319\u201326. https:\/\/doi.org\/10.1016\/j.numecd.2006.07.005.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"848_CR18","doi-asserted-by":"publisher","first-page":"279.e1","DOI":"10.1016\/j.ajog.2018.06.017","volume":"219","author":"EA Greenwood","year":"2018","unstructured":"Greenwood EA, Pasch LA, Cedars MI, Legro RS, Huddleston HG. Association among depression, symptom experience, and quality of life in polycystic ovary syndrome. Am J Obstet Gynecol. 2018;219:279.e1.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"848_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/humupd\/dmy007","volume":"24","author":"NS Kakoly","year":"2018","unstructured":"Kakoly NS, Khomami MB, Joham AE, Cooray SD, Misso ML, Norman RJ, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. 2018;24(4):455\u201367. https:\/\/doi.org\/10.1093\/humupd\/dmy007.","journal-title":"Hum Reprod Update"},{"key":"848_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.puhe.2015.08.001","volume":"131","author":"J Dong","year":"2016","unstructured":"Dong J, Ni YQ, Chu X, Liu YQ, Liu GX, Zhao J, et al. Association between the abdominal obesity anthropometric indicators and metabolic disorders in a Chinese population. Public Health. 2016;131:3\u201310. https:\/\/doi.org\/10.1016\/j.puhe.2015.08.001.","journal-title":"Public Health"},{"issue":"2","key":"848_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11906-018-0812-z","volume":"20","author":"MG Saklayen","year":"2018","unstructured":"Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12. https:\/\/doi.org\/10.1007\/s11906-018-0812-z.","journal-title":"Curr Hypertens Rep"},{"key":"848_CR22","doi-asserted-by":"publisher","first-page":"579.e1","DOI":"10.1016\/j.ajog.2016.07.043","volume":"215","author":"AS Dhesi","year":"2016","unstructured":"Dhesi AS, Murtough KL, Lim JK, Schulkin J, McGovern PG, Power ML, et al. Metabolic screening in patients with polycystic ovary syndrome is largely underutilized among obstetrician-gynecologists. Am J Obstet Gynecol. 2016;215:579.e1.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"848_CR23","first-page":"187","volume":"8","author":"R Dumitrescu","year":"2015","unstructured":"Dumitrescu R, Mehedintu C, Briceag I, Purc\u0103rea VL, Hudita D. Metformin-clinical pharmacology in PCOs. J Med Life. 2015;8(2):187\u201392.","journal-title":"J Med Life"},{"issue":"6","key":"848_CR24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0002-9343(97)00254-4","volume":"103","author":"AJ Garber","year":"1997","unstructured":"Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med. 1997;103(6):491\u20137. https:\/\/doi.org\/10.1016\/S0002-9343(97)00254-4.","journal-title":"Am J Med"},{"issue":"1","key":"848_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/CEJ.0000000000000078","volume":"24","author":"X Zhao","year":"2015","unstructured":"Zhao X, Li Y, Chen M, Chen Y, Dai Y, Wang Y, et al. Effects of different doses of metformin treatment for 6 months on aberrant crypt foci in Chinese patients with impaired glucose tolerance. Eur J Cancer Prev. 2015;24(1):27\u201336. https:\/\/doi.org\/10.1097\/CEJ.0000000000000078.","journal-title":"Eur J Cancer Prev"},{"issue":"10","key":"848_CR26","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1093\/humrep\/des262","volume":"27","author":"AM Fulghesu","year":"2012","unstructured":"Fulghesu AM, Romualdi D, Di Florio C, Sanna S, Tagliaferri V, Gambineri A, et al. Is there a dose-response relationship of metformin treatment in patients with polycystic ovary syndrome? Results from a multicentric study. Hum Reprod. 2012;27(10):3057\u201366. https:\/\/doi.org\/10.1093\/humrep\/des262.","journal-title":"Hum Reprod"},{"issue":"8","key":"848_CR27","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1210\/jc.2004-2283","volume":"90","author":"LR Harborne","year":"2005","unstructured":"Harborne LR, Sattar N, Norman JE, Fleming R. Metformin and weight loss in obese women with polycystic ovary syndrome: comparison of doses. J Clin Endocrinol Metab. 2005;90(8):4593\u20138. https:\/\/doi.org\/10.1210\/jc.2004-2283.","journal-title":"J Clin Endocrinol Metab"},{"key":"848_CR28","first-page":"6619597","volume":"2021","author":"W Shen","year":"2021","unstructured":"Shen W, Jin B, Pan Y, Han Y, You T, Zhang Z, et al. The effects of traditional Chinese medicine-associated complementary and alternative medicine on women with polycystic ovary syndrome. Evid Based Complement Alternat Med. 2021;2021:6619597.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"5","key":"848_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/acu.2019.1375","volume":"31","author":"J Yang","year":"2019","unstructured":"Yang J, Chon TY, Bauer BA. Use of acupuncture in overweight\/obese women with polycystic ovary syndrome. Med Acupunct. 2019;31(5):267\u20138. https:\/\/doi.org\/10.1089\/acu.2019.1375.","journal-title":"Med Acupunct"},{"issue":"4","key":"848_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/dom.12849","volume":"19","author":"ZZ Htike","year":"2017","unstructured":"Htike ZZ, Zaccardi F, Papamargaritis D, Webb DR, Khunti K, Davies MJ. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a systematic review and mixed-treatment comparison analysis. Diabetes Obes Metab. 2017;19(4):524\u201336. https:\/\/doi.org\/10.1111\/dom.12849.","journal-title":"Diabetes Obes Metab"},{"key":"848_CR31","doi-asserted-by":"publisher","first-page":"d7771","DOI":"10.1136\/bmj.d7771","volume":"344","author":"T Vilsb\u00f8ll","year":"2012","unstructured":"Vilsb\u00f8ll T, Christensen M, Junker AE, Knop FK, Gluud LL. Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. BMJ (Clinical research ed). 2012;344:d7771.","journal-title":"BMJ (Clinical research ed)"},{"issue":"7","key":"848_CR32","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1210\/jc.2008-0115","volume":"93","author":"K Elkind-Hirsch","year":"2008","unstructured":"Elkind-Hirsch K, Marrioneaux O, Bhushan M, Vernor D, Bhushan R. Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93(7):2670\u20138. https:\/\/doi.org\/10.1210\/jc.2008-0115.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00848-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-021-00848-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00848-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T13:04:03Z","timestamp":1630933443000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-021-00848-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["848"],"URL":"https:\/\/doi.org\/10.1186\/s12902-021-00848-w","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"assertion":[{"value":"15 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (No. S-K1373). Written informed consent was obtained from all participants prior to the online survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}